Nirland Ltd

CIK: 0001994188

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CDT

CONDUIT PHARMACEUTICALS INC.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CDT
CONDUIT PHARMACEUTICALS INC.
Oct 7, 2024
Sale(S)
Direct
939K shares at avg. $0.10$97K
CDT
CONDUIT PHARMACEUTICALS INC.
Oct 4, 2024
Sale(S)
Direct
1.4M shares at avg. $0.10$140K
CDT
CONDUIT PHARMACEUTICALS INC.
Oct 3, 2024
Sale(S)
Direct
1.5M shares at avg. $0.10$156K
CDT
CONDUIT PHARMACEUTICALS INC.
Oct 2, 2024
Sale(S)
Direct
333.2K shares at avg. $0.10$34K
CDT
CONDUIT PHARMACEUTICALS INC.
Oct 1, 2024
Sale(S)
Direct
1.3M shares at avg. $0.11$141K
CDT
CONDUIT PHARMACEUTICALS INC.
Sep 30, 2024
Sale(S)
Direct
1M shares at avg. $0.12$122K

		Type	Shares	Price		Ownership
Oct 7, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	939,009	$0.10	$96,530	Direct
Oct 4, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	1,368,991	$0.10	$140,458	Direct
Oct 3, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	1,500,000	$0.10	$156,450	Direct
Oct 2, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	333,177	$0.10	$34,251	Direct
Oct 1, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	1,250,000	$0.11	$141,375	Direct
Sep 30, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	1,016,823	$0.12	$122,019	Direct

1-6 of 6 transactions

About Nirland Ltd

Nirland Ltd (SEC CIK 0001994188) files insider reports with the SEC as 10% Owner of CONDUIT PHARMACEUTICALS INC. (CDT).

Signal8 holds 2 ownership filings by Nirland Ltd, all Form 4s, filed between Oct 2, 2024 and Oct 7, 2024. Those filings report 6 transactions, from Sep 30, 2024 to Oct 7, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Nirland Ltd's filings is in ST PETER PORT, Y7.

Recent filings by Nirland Ltd

Oct 7, 2024: Open-market sale of CDT shares (Form 4, code S).
Oct 4, 2024: Open-market sale of CDT shares (Form 4, code S).
Oct 3, 2024: Open-market sale of CDT shares (Form 4, code S).
Oct 2, 2024: Open-market sale of CDT shares (Form 4, code S).
Oct 1, 2024: Open-market sale of CDT shares (Form 4, code S).

Other insiders filing for CONDUIT PHARMACEUTICALS INC. (CDT)

Regan Andrew, Chief Executive Officer
Manoira Corp, 10% Owner
Taylor Mark Andrew, 10% Owner
Farley Chele Chiavacci, Director
Bligh James, Interim CFO
Fry Simon Jeremy, Director

How to read Form 4 transaction codes